Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Adrianne R Wilson-Poe

6 papers in the library · 22 citations · publishing 2024-2026

Papers

Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study

Journal of Psychopharmacology June 18, 2024 Kim Hoffman, Alissa Bazinet, Kellie Pertl et al. 14 citations

Experts with extensive experience facilitating psilocybin experiences, including in ceremonial settings, indigenous practices, and clinical trials, developed a set of core measures to monitor the safety, quality, and outcomes of supervised psilocybin services. Through a three-phase e-Delphi process with 36 experts, 55 candidate measures were identified and then prioritized to a core set of 11 process measures (e.g., preparatory hours with client, documentation of touch/sexual boundaries), 11 outcome measures (e.g., adverse events, well-being), and 17 structure measures (e.g., facilitator training in trauma informed care). The findings suggest that service providers and policy makers should consider standardizing these measures for community-based psilocybin services.

Building standards of psychedelic care: Qualitative examination of expert perspectives on safety, inclusion, and accountability.

The International journal on drug policy January 1, 2026 Christina Chwyl, Adrianne R Wilson-Poe, Kim Hoffman et al. 3 citations

Experts in psychedelic care and harm reduction identified five key areas for improving standards of care: strengthening provider accountability and credibility, advancing culturally responsive and inclusive practices, emphasizing community-based support and integration, ensuring safety through preparation and screening, and navigating legal and informational gray areas. The findings highlight the need for clearer guidelines, robust safety protocols, and accessible support systems to optimize outcomes across diverse populations and settings.

Oregon’s Emerging Psilocybin Services Workforce: A Survey of the First Legal Psilocybin Facilitators and Their Training Programs

Journal of Psychoactive Drugs January 29, 2025 Jason B. Luoma, Kim Hoffman, Adrianne R Wilson-Poe et al. 3 citations

Oregon's early psilocybin facilitator workforce is relatively diverse, with many holding existing healthcare licenses. Among 16 active training programs, mean tuition was $9,359 and half offered diversity scholarships. Survey respondents (n=106) reported that training expenses were a moderate-to-severe financial strain, though most were satisfied with their training. The mean planned price for a session was $1,388, and common specializations included trauma, mental disorders, consciousness exploration, and spirituality. Facilitators requested ongoing training opportunities. These findings are crucial for informing future policy and training program development to support a diverse and effective workforce.

Commentary on Darkeet al.: Expanded psychedelic access requires new safety monitoring systems

Addiction June 17, 2024 P. Todd Korthuis, Adrianne R Wilson-Poe, Joshua C. Black et al. 1 citation

As psychedelic use expands, adverse effects will increase proportionally. Darke et al. characterized 33 LSD and 10 psilocybin-related deaths in Australia between 2000 and 2023, finding that traumatic accidents and physical self-harm in private settings accounted for most deaths. The 43 deaths over 24 years are rare compared to the more than 325,000 Australians who reported using hallucinogens in 2019 alone. Co-use of other substances was common: 75% of LSD cases and 80% of psilocybin cases involved other substances. The findings suggest regulated services must consider harm reduction, including skilled supervision, screening for comorbidities, and counseling against other drug use. Better population-level monitoring frameworks are urgently needed as legal frameworks for psychedelic services expand.

Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative Study

Neuroethics May 13, 2026 Christina Chwyl, Alissa Bazinet, Adrianne R Wilson-Poe et al.

Informed consent in psychedelic-assisted services is ethically complex and lacks standardization. Expert recommendations from 36 participants (71% white, 53% female, average 15.2 years of experience in clinical trial, underground, or ceremonial settings) emphasized that consent should be an ongoing process built on a strong therapeutic relationship and client empowerment. Comprehensive disclosure of risks and benefits is needed, including long-term psychological and social changes and the possibility of disappointing experiences. Detailed consent around touch and boundaries is crucial, with explicit boundary-setting before administration and attention to non-verbal cues. Provider training should cultivate deep respect for client agency and experiential learning of relational and boundary skills.